No abstract

Introduction: Originated in China in December 2019 Corona virus disease (COVID-19) has rapidly spread to around 216 countries in the world by May 2020. Dentists being at a higher risk of contacting the disease, the present study assessed the fear and anxiety among dental practitioners of COVID-19. Methodology: An online cross-sectional questionnaire survey comprising of nine questions was conducted among dental practitioners of Telangana. Age, gender, qualification, type of practice, years of practice, place of residence were the demographic variables recorded. The response to each question was recorded in a YES or NO format, mean fear score calculated to categorize into low and high levels of fear. Comparison of mean fear score was done using t- test for two variables and ANOVA for three or more than three variables. Multiple logistic regression analysis of the levels of fear with demographic variables was done. p<0.05 was considered statistically significant. Results : The mean fear and anxiety score of this study population reported was high 6.57 +2.07, with 58.31% of the population presenting with a low level of fear and anxiety. Only qualification (p=0.045)and gender (p=0.035) revealed a significant difference in fear to Q7and Q8 respectively. Irrespective of the age, gender, qualification, type of practice and years of practices the levels of fear reported in the present study was high similar. Respondents between 41- 60 yrs age (6.70+ 2.01) and those with individual practices (6.70+2.06) exhibited high level of fear score. Conclusion: The present study demonstrates a cross sectional data of fear and anxiety among dental practitioners during the COVID-19 outbreak. Heightened levels of fear observed call for a nationwide analysis of fear among dentists and deliberate management strategies for the same.

No abstract

Uterine sarcomas are uncommon and aggressive tumors comprising 3-7% of all uterine malignancies. The aim is to evaluate clinical presentation, histopathologic pattern, recurrence pattern, and outcome of patients with uterine sarcomas presenting to a tertiary care cancer center over an 8-year period. A total of 11 cases of uterine sarcoma were diagnosed. The median age of patients at presentation was 51 years (range 30-67 years). Six patients had leiomyosarcoma (54.5%), 4 had endometrial stromal sarcoma (36%), and 1 had adenosarcoma (9%). The main presenting symptoms were abnormal vaginal bleeding, low abdominal pain, and white discharge. Median follow-up was 11 months ranging from 3 to 200 months. Median survivals for leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma were 6.5, 18, and 56 months. The 3-and 5-year survival by Kaplan-Meier survival analysis of the entire cohort was 30 and 20%. The mitotic index, age, adjuvant therapy (chemotherapy, radiotherapy), and performance of pelvic nodal dissection did not impact survival significantly in the patient with leiomyosarcoma. Stage and histology had the strongest bearing on survival and leiomyosarcoma has the worst survival, whereas adenosarcoma had the best prognosis. Adequately powered prospective studies are required to define the role of radiation therapy and chemotherapy in this rare disease.